nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCG2—Vandetanib—thyroid cancer	0.19	0.254	CbGbCtD
Rilpivirine—ABCG2—Sorafenib—thyroid cancer	0.114	0.153	CbGbCtD
Rilpivirine—CYP2B6—Sorafenib—thyroid cancer	0.0805	0.108	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—thyroid cancer	0.0694	0.0928	CbGbCtD
Rilpivirine—CYP2C19—Sorafenib—thyroid cancer	0.0511	0.0683	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—thyroid cancer	0.0488	0.0652	CbGbCtD
Rilpivirine—CYP1A2—Sorafenib—thyroid cancer	0.0472	0.063	CbGbCtD
Rilpivirine—ABCB1—Sorafenib—thyroid cancer	0.0413	0.0551	CbGbCtD
Rilpivirine—CYP3A4—Vandetanib—thyroid cancer	0.041	0.0548	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—thyroid cancer	0.025	0.0335	CbGbCtD
Rilpivirine—CYP3A4—Sorafenib—thyroid cancer	0.0247	0.033	CbGbCtD
Rilpivirine—Urogenital disorder—Sorafenib—thyroid cancer	0.0159	0.075	CcSEcCtD
Rilpivirine—CYP3A4—Doxorubicin—thyroid cancer	0.015	0.02	CbGbCtD
Rilpivirine—Lipase increased—Sorafenib—thyroid cancer	0.00889	0.0419	CcSEcCtD
Rilpivirine—White blood cell count decreased—Vandetanib—thyroid cancer	0.00778	0.0367	CcSEcCtD
Rilpivirine—Cholecystitis—Vandetanib—thyroid cancer	0.00674	0.0318	CcSEcCtD
Rilpivirine—Platelet count decreased—Vandetanib—thyroid cancer	0.00651	0.0307	CcSEcCtD
Rilpivirine—Serum creatinine increased—Vandetanib—thyroid cancer	0.0063	0.0297	CcSEcCtD
Rilpivirine—Cholelithiasis—Vandetanib—thyroid cancer	0.00623	0.0293	CcSEcCtD
Rilpivirine—Haemoglobin decreased—Vandetanib—thyroid cancer	0.00563	0.0265	CcSEcCtD
Rilpivirine—Nephrotic syndrome—Sorafenib—thyroid cancer	0.00541	0.0255	CcSEcCtD
Rilpivirine—Nephrolithiasis—Vandetanib—thyroid cancer	0.00482	0.0227	CcSEcCtD
Rilpivirine—Bilirubin total increased—Epirubicin—thyroid cancer	0.00481	0.0227	CcSEcCtD
Rilpivirine—Cholecystitis—Sorafenib—thyroid cancer	0.00455	0.0214	CcSEcCtD
Rilpivirine—Bilirubin total increased—Doxorubicin—thyroid cancer	0.00445	0.021	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Vandetanib—thyroid cancer	0.0041	0.0193	CcSEcCtD
Rilpivirine—Creatinine increased—Vandetanib—thyroid cancer	0.00407	0.0192	CcSEcCtD
Rilpivirine—Haemoglobin decreased—Sorafenib—thyroid cancer	0.0038	0.0179	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—THRB—thyroid cancer	0.00337	0.086	CbGpPWpGaD
Rilpivirine—Blood bilirubin increased—Sorafenib—thyroid cancer	0.00276	0.013	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00266	0.0679	CbGpPWpGaD
Rilpivirine—Blood creatinine increased—Vandetanib—thyroid cancer	0.00263	0.0124	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00248	0.0117	CcSEcCtD
Rilpivirine—Opportunistic infection—Epirubicin—thyroid cancer	0.0024	0.0113	CcSEcCtD
Rilpivirine—Opportunistic infection—Doxorubicin—thyroid cancer	0.00222	0.0104	CcSEcCtD
Rilpivirine—Depression—Vandetanib—thyroid cancer	0.00216	0.0102	CcSEcCtD
Rilpivirine—Renal failure—Vandetanib—thyroid cancer	0.00213	0.01	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00205	0.00965	CcSEcCtD
Rilpivirine—Urinary tract disorder—Vandetanib—thyroid cancer	0.00192	0.00904	CcSEcCtD
Rilpivirine—Urethral disorder—Vandetanib—thyroid cancer	0.00191	0.00898	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00171	0.00804	CcSEcCtD
Rilpivirine—Mental disorder—Vandetanib—thyroid cancer	0.0017	0.00802	CcSEcCtD
Rilpivirine—Malnutrition—Vandetanib—thyroid cancer	0.00169	0.00797	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00167	0.00788	CcSEcCtD
Rilpivirine—SLCO1B3—Recycling of bile acids and salts—RXRA—thyroid cancer	0.0016	0.0407	CbGpPWpGaD
Rilpivirine—Transaminases increased—Epirubicin—thyroid cancer	0.00159	0.00747	CcSEcCtD
Rilpivirine—Abdominal discomfort—Sorafenib—thyroid cancer	0.00157	0.0074	CcSEcCtD
Rilpivirine—Serum creatinine increased—Epirubicin—thyroid cancer	0.00157	0.00739	CcSEcCtD
Rilpivirine—Transaminases increased—Doxorubicin—thyroid cancer	0.00147	0.00692	CcSEcCtD
Rilpivirine—Serum creatinine increased—Doxorubicin—thyroid cancer	0.00145	0.00684	CcSEcCtD
Rilpivirine—Renal failure—Sorafenib—thyroid cancer	0.00144	0.00677	CcSEcCtD
Rilpivirine—Anxiety—Vandetanib—thyroid cancer	0.00144	0.00676	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—RXRA—thyroid cancer	0.00143	0.0365	CbGpPWpGaD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00143	0.00674	CcSEcCtD
Rilpivirine—Dry mouth—Vandetanib—thyroid cancer	0.00141	0.00664	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00138	0.00651	CcSEcCtD
Rilpivirine—Infection—Vandetanib—thyroid cancer	0.00137	0.00646	CcSEcCtD
Rilpivirine—Nervous system disorder—Vandetanib—thyroid cancer	0.00136	0.00638	CcSEcCtD
Rilpivirine—Skin disorder—Vandetanib—thyroid cancer	0.00134	0.00632	CcSEcCtD
Rilpivirine—Urinary tract disorder—Sorafenib—thyroid cancer	0.0013	0.0061	CcSEcCtD
Rilpivirine—Urethral disorder—Sorafenib—thyroid cancer	0.00129	0.00606	CcSEcCtD
Rilpivirine—Insomnia—Vandetanib—thyroid cancer	0.00125	0.00589	CcSEcCtD
Rilpivirine—Decreased appetite—Vandetanib—thyroid cancer	0.0012	0.00566	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00119	0.00562	CcSEcCtD
Rilpivirine—Fatigue—Vandetanib—thyroid cancer	0.00119	0.00561	CcSEcCtD
Rilpivirine—Immune system disorder—Sorafenib—thyroid cancer	0.00119	0.00558	CcSEcCtD
Rilpivirine—Mental disorder—Sorafenib—thyroid cancer	0.00115	0.00541	CcSEcCtD
Rilpivirine—Malnutrition—Sorafenib—thyroid cancer	0.00114	0.00538	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00113	0.0289	CbGpPWpGaD
Rilpivirine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00113	0.00532	CcSEcCtD
Rilpivirine—Abdominal pain—Vandetanib—thyroid cancer	0.00109	0.00514	CcSEcCtD
Rilpivirine—SLCO1B1—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00107	0.0274	CbGpPWpGaD
Rilpivirine—CYP2B6—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00106	0.027	CbGpPWpGaD
Rilpivirine—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00102	0.00481	CcSEcCtD
Rilpivirine—Creatinine increased—Epirubicin—thyroid cancer	0.00101	0.00478	CcSEcCtD
Rilpivirine—Inflammation—Epirubicin—thyroid cancer	0.000996	0.00469	CcSEcCtD
Rilpivirine—Asthenia—Vandetanib—thyroid cancer	0.000991	0.00467	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000988	0.0252	CbGpPWpGaD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000966	0.00455	CcSEcCtD
Rilpivirine—Abnormal dreams—Epirubicin—thyroid cancer	0.000954	0.00449	CcSEcCtD
Rilpivirine—Dry mouth—Sorafenib—thyroid cancer	0.000951	0.00448	CcSEcCtD
Rilpivirine—Diarrhoea—Vandetanib—thyroid cancer	0.000946	0.00445	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.000945	0.00445	CcSEcCtD
Rilpivirine—Creatinine increased—Doxorubicin—thyroid cancer	0.000939	0.00442	CcSEcCtD
Rilpivirine—Infection—Sorafenib—thyroid cancer	0.000926	0.00436	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—thyroid cancer	0.000921	0.00434	CcSEcCtD
Rilpivirine—Nervous system disorder—Sorafenib—thyroid cancer	0.000914	0.0043	CcSEcCtD
Rilpivirine—Dizziness—Vandetanib—thyroid cancer	0.000914	0.0043	CcSEcCtD
Rilpivirine—Skin disorder—Sorafenib—thyroid cancer	0.000905	0.00426	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—PPARG—thyroid cancer	0.000904	0.0231	CbGpPWpGaD
Rilpivirine—Abnormal dreams—Doxorubicin—thyroid cancer	0.000883	0.00416	CcSEcCtD
Rilpivirine—Vomiting—Vandetanib—thyroid cancer	0.000879	0.00414	CcSEcCtD
Rilpivirine—Rash—Vandetanib—thyroid cancer	0.000871	0.0041	CcSEcCtD
Rilpivirine—Dermatitis—Vandetanib—thyroid cancer	0.000871	0.0041	CcSEcCtD
Rilpivirine—Headache—Vandetanib—thyroid cancer	0.000866	0.00408	CcSEcCtD
Rilpivirine—SLCO1B3—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000835	0.0213	CbGpPWpGaD
Rilpivirine—Nausea—Vandetanib—thyroid cancer	0.000821	0.00387	CcSEcCtD
Rilpivirine—Decreased appetite—Sorafenib—thyroid cancer	0.00081	0.00382	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000805	0.00379	CcSEcCtD
Rilpivirine—Fatigue—Sorafenib—thyroid cancer	0.000804	0.00378	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000762	0.00359	CcSEcCtD
Rilpivirine—Abdominal pain—Sorafenib—thyroid cancer	0.000737	0.00347	CcSEcCtD
Rilpivirine—Renal impairment—Epirubicin—thyroid cancer	0.000737	0.00347	CcSEcCtD
Rilpivirine—ABCG2—Iron uptake and transport—CP—thyroid cancer	0.000716	0.0183	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000714	0.0182	CbGpPWpGaD
Rilpivirine—Renal impairment—Doxorubicin—thyroid cancer	0.000681	0.00321	CcSEcCtD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—EPO—thyroid cancer	0.000678	0.0173	CbGpPWpGaD
Rilpivirine—Asthenia—Sorafenib—thyroid cancer	0.000669	0.00315	CcSEcCtD
Rilpivirine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000657	0.00309	CcSEcCtD
Rilpivirine—Diarrhoea—Sorafenib—thyroid cancer	0.000638	0.003	CcSEcCtD
Rilpivirine—NR1I2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000636	0.0162	CbGpPWpGaD
Rilpivirine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000631	0.00297	CcSEcCtD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00062	0.0158	CbGpPWpGaD
Rilpivirine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000618	0.00291	CcSEcCtD
Rilpivirine—Dizziness—Sorafenib—thyroid cancer	0.000616	0.0029	CcSEcCtD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000612	0.0156	CbGpPWpGaD
Rilpivirine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000608	0.00286	CcSEcCtD
Rilpivirine—Vomiting—Sorafenib—thyroid cancer	0.000593	0.00279	CcSEcCtD
Rilpivirine—Rash—Sorafenib—thyroid cancer	0.000588	0.00277	CcSEcCtD
Rilpivirine—Dermatitis—Sorafenib—thyroid cancer	0.000587	0.00277	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000584	0.00275	CcSEcCtD
Rilpivirine—Headache—Sorafenib—thyroid cancer	0.000584	0.00275	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000572	0.00269	CcSEcCtD
Rilpivirine—SLCO1B1—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000561	0.0143	CbGpPWpGaD
Rilpivirine—Nausea—Sorafenib—thyroid cancer	0.000554	0.00261	CcSEcCtD
Rilpivirine—Renal failure—Epirubicin—thyroid cancer	0.000531	0.0025	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000511	0.00241	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000508	0.013	CbGpPWpGaD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000506	0.0129	CbGpPWpGaD
Rilpivirine—Renal failure—Doxorubicin—thyroid cancer	0.000491	0.00231	CcSEcCtD
Rilpivirine—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000482	0.0123	CbGpPWpGaD
Rilpivirine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000479	0.00225	CcSEcCtD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000477	0.0122	CbGpPWpGaD
Rilpivirine—Urethral disorder—Epirubicin—thyroid cancer	0.000475	0.00224	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000473	0.00223	CcSEcCtD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000466	0.0119	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—THRB—thyroid cancer	0.00046	0.0117	CbGpPWpGaD
Rilpivirine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000443	0.00209	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—thyroid cancer	0.00044	0.00207	CcSEcCtD
Rilpivirine—Immune system disorder—Epirubicin—thyroid cancer	0.000438	0.00206	CcSEcCtD
Rilpivirine—Mental disorder—Epirubicin—thyroid cancer	0.000425	0.002	CcSEcCtD
Rilpivirine—Malnutrition—Epirubicin—thyroid cancer	0.000422	0.00199	CcSEcCtD
Rilpivirine—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000418	0.0107	CbGpPWpGaD
Rilpivirine—Immune system disorder—Doxorubicin—thyroid cancer	0.000405	0.00191	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000399	0.0102	CbGpPWpGaD
Rilpivirine—Mental disorder—Doxorubicin—thyroid cancer	0.000393	0.00185	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—thyroid cancer	0.000391	0.00184	CcSEcCtD
Rilpivirine—CYP2B6—Metapathway biotransformation—CHST14—thyroid cancer	0.000369	0.00941	CbGpPWpGaD
Rilpivirine—Anxiety—Epirubicin—thyroid cancer	0.000358	0.00169	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000357	0.00168	CcSEcCtD
Rilpivirine—Dry mouth—Epirubicin—thyroid cancer	0.000351	0.00165	CcSEcCtD
Rilpivirine—Infection—Epirubicin—thyroid cancer	0.000342	0.00161	CcSEcCtD
Rilpivirine—Nervous system disorder—Epirubicin—thyroid cancer	0.000338	0.00159	CcSEcCtD
Rilpivirine—Skin disorder—Epirubicin—thyroid cancer	0.000335	0.00158	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—thyroid cancer	0.000331	0.00156	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00033	0.00155	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—thyroid cancer	0.000325	0.00153	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—thyroid cancer	0.000317	0.00149	CcSEcCtD
Rilpivirine—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000316	0.00806	CbGpPWpGaD
Rilpivirine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000313	0.00147	CcSEcCtD
Rilpivirine—Insomnia—Epirubicin—thyroid cancer	0.000312	0.00147	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—thyroid cancer	0.00031	0.00146	CcSEcCtD
Rilpivirine—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000308	0.00787	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—TRIM33—thyroid cancer	0.000306	0.00781	CbGpPWpGaD
Rilpivirine—Somnolence—Epirubicin—thyroid cancer	0.000306	0.00144	CcSEcCtD
Rilpivirine—Decreased appetite—Epirubicin—thyroid cancer	0.000299	0.00141	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000297	0.0014	CcSEcCtD
Rilpivirine—Fatigue—Epirubicin—thyroid cancer	0.000297	0.0014	CcSEcCtD
Rilpivirine—NR1I2—Generic Transcription Pathway—MEN1—thyroid cancer	0.000292	0.00745	CbGpPWpGaD
Rilpivirine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000288	0.00736	CbGpPWpGaD
Rilpivirine—Insomnia—Doxorubicin—thyroid cancer	0.000288	0.00136	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—thyroid cancer	0.000283	0.00133	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000282	0.00133	CcSEcCtD
Rilpivirine—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000279	0.00711	CbGpPWpGaD
Rilpivirine—Decreased appetite—Doxorubicin—thyroid cancer	0.000277	0.0013	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000275	0.0013	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—thyroid cancer	0.000275	0.00129	CcSEcCtD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000275	0.00701	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000274	0.00698	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000273	0.00696	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000273	0.00696	CbGpPWpGaD
Rilpivirine—Abdominal pain—Epirubicin—thyroid cancer	0.000272	0.00128	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000261	0.00123	CcSEcCtD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000254	0.00648	CbGpPWpGaD
Rilpivirine—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000253	0.00645	CbGpPWpGaD
Rilpivirine—Abdominal pain—Doxorubicin—thyroid cancer	0.000252	0.00119	CcSEcCtD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000252	0.00642	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000248	0.00633	CbGpPWpGaD
Rilpivirine—Asthenia—Epirubicin—thyroid cancer	0.000247	0.00116	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000237	0.00606	CbGpPWpGaD
Rilpivirine—Diarrhoea—Epirubicin—thyroid cancer	0.000236	0.00111	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—thyroid cancer	0.000229	0.00108	CcSEcCtD
Rilpivirine—Dizziness—Epirubicin—thyroid cancer	0.000228	0.00107	CcSEcCtD
Rilpivirine—NR1I2—Gene Expression—THRB—thyroid cancer	0.000221	0.00565	CbGpPWpGaD
Rilpivirine—Vomiting—Epirubicin—thyroid cancer	0.000219	0.00103	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—thyroid cancer	0.000218	0.00103	CcSEcCtD
Rilpivirine—Rash—Epirubicin—thyroid cancer	0.000217	0.00102	CcSEcCtD
Rilpivirine—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000217	0.00554	CbGpPWpGaD
Rilpivirine—Dermatitis—Epirubicin—thyroid cancer	0.000217	0.00102	CcSEcCtD
Rilpivirine—Headache—Epirubicin—thyroid cancer	0.000216	0.00102	CcSEcCtD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000216	0.0055	CbGpPWpGaD
Rilpivirine—Dizziness—Doxorubicin—thyroid cancer	0.000211	0.000993	CcSEcCtD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000205	0.00523	CbGpPWpGaD
Rilpivirine—Nausea—Epirubicin—thyroid cancer	0.000205	0.000964	CcSEcCtD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000204	0.00521	CbGpPWpGaD
Rilpivirine—Vomiting—Doxorubicin—thyroid cancer	0.000203	0.000954	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—thyroid cancer	0.000201	0.000946	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—thyroid cancer	0.000201	0.000946	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—thyroid cancer	0.0002	0.00094	CcSEcCtD
Rilpivirine—NR1I2—Generic Transcription Pathway—RXRA—thyroid cancer	0.000195	0.00499	CbGpPWpGaD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000191	0.00487	CbGpPWpGaD
Rilpivirine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00019	0.00485	CbGpPWpGaD
Rilpivirine—Nausea—Doxorubicin—thyroid cancer	0.000189	0.000892	CcSEcCtD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000186	0.00473	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000183	0.00468	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000183	0.00468	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—MINPP1—thyroid cancer	0.000175	0.00448	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000171	0.00435	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000168	0.00428	CbGpPWpGaD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000165	0.0042	CbGpPWpGaD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000155	0.00395	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—TPR—thyroid cancer	0.00015	0.00382	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NDUFA13—thyroid cancer	0.000149	0.00381	CbGpPWpGaD
Rilpivirine—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000149	0.0038	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000148	0.00378	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MEN1—thyroid cancer	0.000141	0.00359	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CHST14—thyroid cancer	0.00014	0.00358	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000139	0.00354	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000139	0.00354	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000137	0.0035	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000136	0.00348	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000134	0.00342	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000128	0.00327	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—PPARG—thyroid cancer	0.000123	0.00315	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000121	0.00308	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—MINPP1—thyroid cancer	0.000118	0.00301	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000115	0.00293	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000114	0.00292	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—HPGD—thyroid cancer	0.000113	0.00288	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00011	0.0028	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—MINPP1—thyroid cancer	0.000109	0.00278	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—RXRA—thyroid cancer	0.000109	0.00278	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000104	0.00265	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	0.0001	0.00256	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CHST14—thyroid cancer	9.42e-05	0.0024	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—RXRA—thyroid cancer	9.41e-05	0.0024	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.32e-05	0.00238	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	9.32e-05	0.00238	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	9.32e-05	0.00238	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NDUFA13—thyroid cancer	9.28e-05	0.00237	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.17e-05	0.00234	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.16e-05	0.00234	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	9.15e-05	0.00233	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.75e-05	0.00223	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CHST14—thyroid cancer	8.73e-05	0.00223	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.72e-05	0.00222	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.63e-05	0.0022	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	8.63e-05	0.0022	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.56e-05	0.00218	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.49e-05	0.00216	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	8.23e-05	0.0021	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—MINPP1—thyroid cancer	8e-05	0.00204	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	7.98e-05	0.00204	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—HPGD—thyroid cancer	7.6e-05	0.00194	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	7.39e-05	0.00188	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	7.12e-05	0.00182	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—HPGD—thyroid cancer	7.03e-05	0.00179	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.97e-05	0.00178	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.82e-05	0.00174	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NDUFA13—thyroid cancer	6.8e-05	0.00174	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—TPR—thyroid cancer	6.49e-05	0.00166	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.46e-05	0.00165	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—RXRA—thyroid cancer	6.41e-05	0.00164	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CHST14—thyroid cancer	6.4e-05	0.00163	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	6.39e-05	0.00163	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.16e-05	0.00157	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	6.13e-05	0.00156	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—MINPP1—thyroid cancer	6.05e-05	0.00154	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PPARG—thyroid cancer	5.94e-05	0.00152	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—MINPP1—thyroid cancer	5.9e-05	0.00151	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.86e-05	0.00149	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.79e-05	0.00148	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.42e-05	0.00138	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.21e-05	0.00133	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—HPGD—thyroid cancer	5.16e-05	0.00132	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	5.14e-05	0.00131	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NDUFA13—thyroid cancer	5.02e-05	0.00128	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	4.95e-05	0.00126	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	4.86e-05	0.00124	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CHST14—thyroid cancer	4.83e-05	0.00123	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CHST14—thyroid cancer	4.72e-05	0.0012	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MINPP1—thyroid cancer	4.71e-05	0.0012	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	4.66e-05	0.00119	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	4.66e-05	0.00119	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.59e-05	0.00117	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.55e-05	0.00116	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TPR—thyroid cancer	4.36e-05	0.00111	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	4.31e-05	0.0011	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	4.29e-05	0.00109	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—RXRA—thyroid cancer	4.08e-05	0.00104	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TPR—thyroid cancer	4.04e-05	0.00103	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	4.01e-05	0.00102	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PRKAR1A—thyroid cancer	3.97e-05	0.00101	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.97e-05	0.00101	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HPGD—thyroid cancer	3.9e-05	0.000994	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.89e-05	0.000992	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HPGD—thyroid cancer	3.8e-05	0.00097	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CHST14—thyroid cancer	3.77e-05	0.000961	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.67e-05	0.000936	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.64e-05	0.000927	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.49e-05	0.00089	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.32e-05	0.000846	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	3.27e-05	0.000833	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.2e-05	0.000816	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.16e-05	0.000806	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.09e-05	0.000789	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.06e-05	0.000781	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HPGD—thyroid cancer	3.04e-05	0.000774	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SLC5A5—thyroid cancer	3.02e-05	0.000771	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TPR—thyroid cancer	2.96e-05	0.000755	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.93e-05	0.000748	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	2.91e-05	0.000743	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CHST14—thyroid cancer	2.91e-05	0.000741	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—RXRA—thyroid cancer	2.74e-05	0.0007	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.67e-05	0.000681	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PPARG—thyroid cancer	2.58e-05	0.000658	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—RXRA—thyroid cancer	2.54e-05	0.000648	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.46e-05	0.000628	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.46e-05	0.000627	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—AKT1—thyroid cancer	2.35e-05	0.000599	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HPGD—thyroid cancer	2.34e-05	0.000598	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TPR—thyroid cancer	2.24e-05	0.000571	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	2.22e-05	0.000565	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.2e-05	0.000562	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TPR—thyroid cancer	2.18e-05	0.000557	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.18e-05	0.000557	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.15e-05	0.000548	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—thyroid cancer	2.03e-05	0.000517	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2e-05	0.000509	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—RXRA—thyroid cancer	1.86e-05	0.000475	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.84e-05	0.00047	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTEN—thyroid cancer	1.77e-05	0.000451	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TPR—thyroid cancer	1.74e-05	0.000445	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.73e-05	0.000442	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.72e-05	0.000438	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.68e-05	0.000427	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.63e-05	0.000417	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARG—thyroid cancer	1.6e-05	0.000409	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.57e-05	0.0004	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.55e-05	0.000397	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—RXRA—thyroid cancer	1.41e-05	0.000359	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—RXRA—thyroid cancer	1.37e-05	0.00035	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.37e-05	0.000349	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.36e-05	0.000348	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TPR—thyroid cancer	1.35e-05	0.000343	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.32e-05	0.000338	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.31e-05	0.000333	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—thyroid cancer	1.26e-05	0.000322	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.22e-05	0.000312	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.19e-05	0.000303	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARG—thyroid cancer	1.18e-05	0.0003	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTEN—thyroid cancer	1.1e-05	0.000281	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.1e-05	0.00028	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.07e-05	0.000272	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—thyroid cancer	1.02e-05	0.00026	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.01e-05	0.000257	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—thyroid cancer	9.25e-06	0.000236	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARG—thyroid cancer	8.89e-06	0.000227	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARG—thyroid cancer	8.67e-06	0.000221	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—RXRA—thyroid cancer	8.46e-06	0.000216	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTEN—thyroid cancer	8.07e-06	0.000206	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—thyroid cancer	6.99e-06	0.000178	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARG—thyroid cancer	6.92e-06	0.000177	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—thyroid cancer	6.85e-06	0.000175	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—thyroid cancer	6.82e-06	0.000174	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—thyroid cancer	6.34e-06	0.000162	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTEN—thyroid cancer	6.1e-06	0.000156	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTEN—thyroid cancer	5.95e-06	0.000152	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.45e-06	0.000139	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARG—thyroid cancer	5.34e-06	0.000136	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTEN—thyroid cancer	4.75e-06	0.000121	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—thyroid cancer	4.65e-06	0.000119	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.2e-06	0.000107	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTEN—thyroid cancer	3.67e-06	9.35e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—thyroid cancer	3.51e-06	8.96e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—thyroid cancer	3.43e-06	8.75e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—thyroid cancer	2.74e-06	6.98e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.11e-06	5.39e-05	CbGpPWpGaD
